Aroa Biosurgery Ltd Total Liabilities
Aroa Biosurgery Ltd total liabilities. Based on the latest financial reports, Aroa Biosurgery Ltd (ARX) has total liabilities worth AU$14.34 Million AUD (≈ $10.15 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Aroa Biosurgery Ltd (ARX) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Aroa Biosurgery Ltd (2001–2025)
Total liabilities of Aroa Biosurgery Ltd from 2001 to 2025. This chart illustrates how Aroa Biosurgery Ltd's total liabilities have evolved over time, based on quarterly financial data.
Aroa Biosurgery Ltd Competitors by Total Liabilities
The table below lists competitors of Aroa Biosurgery Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
STCube Inc
KQ:052020
|
Korea | ₩18.51 Billion |
|
PT Mandiri Herindo Adiperkasa Tbk
JK:MAHA
|
Indonesia | Rp994.58 Billion |
|
Vardhman Holdings Limited
NSE:VHL
|
India | Rs35.50 Million |
|
Excel Industries Limited
NSE:EXCELINDUS
|
India | Rs4.02 Billion |
|
Annehem Fastigheter AB
ST:ANNE-B
|
Sweden | Skr2.76 Billion |
|
Chime Ball Technology Co Ltd
TWO:1595
|
Taiwan | NT$1.31 Billion |
|
Duksan Hi Metal Co.Ltd
KQ:077360
|
Korea | ₩320.20 Billion |
|
Reit Azorim HF Living Ltd
TA:AZRT
|
Israel | ILA2.36 Billion |
Liability Composition Analysis (2001–2025)
This chart breaks down Aroa Biosurgery Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Aroa Biosurgery Ltd asset portfolio.
Liquidity & Leverage Metrics
Aroa Biosurgery Ltd Total Liabilities Ratios Explained
Aroa Biosurgery Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 6.52 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.18 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.15 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Aroa Biosurgery Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Aroa Biosurgery Ltd (2001–2025)
The table below shows the annual total liabilities of Aroa Biosurgery Ltd from 2001 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-03-31 | AU$14.35 Million ≈ $10.15 Million |
-2.98% |
| 2024-03-31 | AU$14.79 Million ≈ $10.46 Million |
+7.97% |
| 2023-03-31 | AU$13.69 Million ≈ $9.69 Million |
+21.15% |
| 2022-03-31 | AU$11.30 Million ≈ $8.00 Million |
-41.83% |
| 2021-03-31 | AU$19.43 Million ≈ $13.75 Million |
-1.24% |
| 2020-03-31 | AU$19.68 Million ≈ $13.92 Million |
-25.58% |
| 2019-03-31 | AU$26.44 Million ≈ $18.71 Million |
+110.93% |
| 2018-03-31 | AU$12.53 Million ≈ $8.87 Million |
+5241.03% |
| 2017-03-31 | AU$234.69K ≈ $166.06K |
-47.09% |
| 2016-03-31 | AU$443.57K ≈ $313.85K |
-24.31% |
| 2015-03-31 | AU$586.00K ≈ $414.63K |
-29.14% |
| 2014-03-31 | AU$827.00K ≈ $585.16K |
+132.96% |
| 2013-03-31 | AU$355.00K ≈ $251.19K |
-77.64% |
| 2012-03-31 | AU$1.59 Million ≈ $1.12 Million |
-52.15% |
| 2011-03-31 | AU$3.32 Million ≈ $2.35 Million |
-3.91% |
| 2010-03-31 | AU$3.45 Million ≈ $2.44 Million |
-96.73% |
| 2009-03-31 | AU$105.73 Million ≈ $74.81 Million |
+17.85% |
| 2008-03-31 | AU$89.72 Million ≈ $63.48 Million |
+54.09% |
| 2007-03-31 | AU$58.23 Million ≈ $41.20 Million |
+626.10% |
| 2006-03-31 | AU$8.02 Million ≈ $5.67 Million |
+83.38% |
| 2005-03-31 | AU$4.37 Million ≈ $3.09 Million |
+69.23% |
| 2004-03-31 | AU$2.58 Million ≈ $1.83 Million |
+9.96% |
| 2003-03-31 | AU$2.35 Million ≈ $1.66 Million |
+6.67% |
| 2002-03-31 | AU$2.20 Million ≈ $1.56 Million |
-81.71% |
| 2001-03-31 | AU$12.04 Million ≈ $8.52 Million |
-- |
About Aroa Biosurgery Ltd
Aroa Biosurgery Limited develops, manufactures, and sells medical devices for wound and soft tissue repair using extracellular matrix (ECM) technology in the United States and internationally. Its products include Endoform Natural and Endoform Antimicrobial Restorative Bioscaffold for treating acute and chronic wounds; Myriad Matrix, an engineered ECM for soft tissue repair, reinforcement, and co… Read more